This report provides comprehensive information on the current therapeutic developmental pipeline of Iroko Pharmaceuticals‚ LLC’s Market‚ complete with comparative analysis at various stages‚ therapeutics assessment by drug target‚ mechanism of action (MoA)‚ route of administration (RoA) and molecule type. It also reviews latest updates‚ and featured news and press releases‚ along with special features on late-stage and discontinued projects. The report features investigational drugs from across
Premium Project management Medicine Drug
The Balanced Scorecard: Omnicare Pharmacy Omnicare Pharmacy is a provider of pharmaceutical care to long-term nursing homes and facilities. The services are focused on the residents we serve and improving their quality of life‚ along with reducing the cost of the pharmacy bill. As a result‚ our vision as a pharmacy provider is to provide the right drug‚ right dose‚ and to the right patient (Omnicare 2010). In order to achieve the vision we have set for ourselves we need
Premium Balanced scorecard Strategy map
The impact of the implementation of single exit pricing for pharmaceuticals in South Africa Daleen Pretorius A research report submitted to the Faculty of Commerce‚ Law and Management‚ University of the Witwatersrand‚ in partial fulfilment of the requirements for the degree of Master of Business Administration Johannesburg‚ 2011 ABSTRACT Pricing regulations have been implemented within the pharmaceutical industry in South Africa to ensure improved access to healthcare. The implementation
Premium Pricing Pharmacy
the latest and sophisticated machines designed for the process easier faster in the pharmaceutical industry. There are labeling machine‚ washing machine‚ powder filling machine‚ grinding mill machine‚ liquid filling machine and so on. Hongxing supply all types of grinding mill machines for pharmacology‚ micro-powder making machine‚ ultra-fine grinder‚ high pressure Raymond mill. Drug grinder for the pharmaceutical‚ chemical and other industries. With the feature of air-cooled‚ no sieve etc. It is
Premium Pharmacology Medicine Pharmaceutical drug
Evaluate and Monitor the company’s Transport Performance - inova Pharmaceuticals pty ltd. Unit: TLIL1907C/TLlL2007C Implement and Monitor Transport Logistic/Develop and Maintain Operational procedures for Transport and Logistics Enterprises- Teacher: Bob Day Prepared by: Ravisanthiran Shanmugarajah Date: 13 June 2012 To: CEO‚ inova pharmaceuticals Pty Ltd Introduction iNova Pharmaceuticals(Australia ) Pty Limited‚ develops and markets over-the-counter and prescription medicines. The product
Premium Logistics Management Transport
Current status on: Biopharming: crops for the production of Therapeutic & Pharmaceutical proteins Biopharming‚ also known as molecular farming‚ is the production of pharmacologically active substances‚ either induced or increased through the application of genetic engineering. The first instance of artificial gene expression in an organism to produce a pharmaceutical product was the synthesis of insulin in the bacterium E. coli (Goeddel et al.‚ 1979). This type of biotechnology has since moved
Premium Biotechnology Cholera Genetically modified organism
Understanding Supply Chain Orientation in Indian Pharmaceutical Firms TOPIC AREA: OPERATIONS AND SUPPLY CHAIN MANAGEMENT Authors: Dr. J Shanmugan‚ Dr. Sajal Kabiraj Email: jshanmugan@skylineuniversity.com‚ skabiraj@skylineuniversity.com Address: Faculty Block 2‚ Skyline University College‚ P.O Box 1797‚ University City of Sharjah‚ Sharjah‚ UAE Tel: 06 5441155 Ext 234‚ 219 A Case Study Approach for Understanding Supply Chain Orientation in Indian Pharmaceutical Firms ABSTRACT Supply Chain
Premium Supply chain management Marketing Supply chain
officer of a large scale company in any field is no easy task. In the pharmaceutical industry the technical specifications make it all the more difficult. The general job description of a CEO in this field is to control daily operations and greatly influence strategic direction‚ working directly with the Board of Directors. The right candidate must have significant senior executive experience leading a biotechnology‚ pharmaceutical and/or medical device company with full profit and loss responsibility
Premium Chief executive officer Executive officer Organizational studies
Pharmaceutical Business Confidence Report Q3 2014 Released On 13th October 2014 Summary "Pharmaceutical Business Confidence Report Q3 2014” is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues‚ and their impact on investment decisions and growth prospects within the pharmaceutical industry. This report also examines executive opinion with regards to the current and future state of the economy and its retrospective effect on the industry
Premium Economics Marketing Marketing research
Researcher’s View: Sourcing accurate and reliable quantitative data on Tanzania’s pharmaceutical market remains challenging due to substandard audits‚ porous sales channels‚ a high prevalence of counterfeits‚ questionable national statistics‚ dispensing without prescriptions‚ sizeable ‘grey markets’ and the widespread use of traditional remedies. Researcher takes into account the import dependence of countries for medicines and assumes that economic growth as well as the resulting increase in the
Premium Economics Medicine Pharmaceutical drug